stockportfolio.pro
Stocks / EW vs IDXX
EW vs IDXX
Edwards Lifesciences Corporation and IDEXX Laboratories, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Edwards Lifesciences Corporation (EW) | IDEXX Laboratories, Inc. (IDXX) | |
|---|---|---|
| Market cap | $50.4B | $45.7B |
| Revenue (latest FY) | $6.07B | $4.30B |
| Net income (latest FY) | $1.07B | $1.06B |
| Revenue growth (5y CAGR) | 6.7% | 9.7% |
| Net margin | 17.7% | 24.6% |
| Return on equity | 10.4% | 66.0% |
| P/E ratio | 47.3 | 42.6 |
| Dividend yield | — | — |
| Profitable years (of last 10) | 5 | 10 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open EW — free Open IDXX — freeFrequently asked questions
Which is bigger, EW or IDXX?
Edwards Lifesciences Corporation is larger by market capitalization — $50.4B versus $45.7B.
Which grows faster, EW or IDXX?
Over the last five fiscal years, IDEXX Laboratories, Inc. grew revenue faster — 9.7%/yr versus 6.7%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.